- 4 of 6 patients responded to therapy, with three of these patients achieving CR- NK cells expanded to median peak of 10-fold (range, 10- to 50- fold) persisted for several months- Adverse effects of CIML NK infusion included: fever, grade 2 CRS (n=1), pancytopenia (n=4), transient increase in ALT/AST (n=1)- No evidence of aGVHD or cGVHD. The gene discussed is GPT; the disease is Pancytopenia.